Jerome E. Tanner

2.2k total citations
34 papers, 1.7k citations indexed

About

Jerome E. Tanner is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Jerome E. Tanner has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Immunology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Jerome E. Tanner's work include Viral-associated cancers and disorders (16 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immune Cell Function and Interaction (7 papers). Jerome E. Tanner is often cited by papers focused on Viral-associated cancers and disorders (16 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immune Cell Function and Interaction (7 papers). Jerome E. Tanner collaborates with scholars based in Canada, United States and Italy. Jerome E. Tanner's co-authors include Caroline Alfieri, Elliott Kieff, Young E. Whang, Douglas T. Fearon, Janis J. Weis, Giovanna Tosato, Sandra E. Pike, Karen D. Jones, Michel Revel and Amy E. Sears and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Blood.

In The Last Decade

Jerome E. Tanner

34 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerome E. Tanner Canada 19 944 581 530 381 374 34 1.7k
J Menezes Canada 23 1.0k 1.1× 702 1.2× 854 1.6× 355 0.9× 427 1.1× 42 1.9k
S. Finerty United Kingdom 22 948 1.0× 361 0.6× 460 0.9× 473 1.2× 358 1.0× 36 1.3k
Neil Blake United Kingdom 23 1.1k 1.1× 1.0k 1.7× 735 1.4× 381 1.0× 155 0.4× 38 2.0k
Caroline Alfieri Canada 21 1.5k 1.6× 493 0.8× 639 1.2× 675 1.8× 585 1.6× 38 2.0k
Jacqueline M. Burrows Australia 26 734 0.8× 1.4k 2.3× 542 1.0× 344 0.9× 163 0.4× 36 2.0k
Chris Dawson United Kingdom 14 891 0.9× 665 1.1× 405 0.8× 264 0.7× 234 0.6× 16 1.8k
Jianmin Zuo United Kingdom 25 1.1k 1.1× 972 1.7× 749 1.4× 288 0.8× 361 1.0× 69 2.0k
I S Misko Australia 27 1.5k 1.6× 1.6k 2.8× 934 1.8× 515 1.4× 376 1.0× 49 2.6k
Dagmar Pich Germany 21 1.5k 1.6× 563 1.0× 935 1.8× 468 1.2× 356 1.0× 29 2.3k
Misako Yajima Japan 15 566 0.6× 458 0.8× 365 0.7× 223 0.6× 151 0.4× 25 1.1k

Countries citing papers authored by Jerome E. Tanner

Since Specialization
Citations

This map shows the geographic impact of Jerome E. Tanner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome E. Tanner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome E. Tanner more than expected).

Fields of papers citing papers by Jerome E. Tanner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome E. Tanner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome E. Tanner. The network helps show where Jerome E. Tanner may publish in the future.

Co-authorship network of co-authors of Jerome E. Tanner

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome E. Tanner. A scholar is included among the top collaborators of Jerome E. Tanner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome E. Tanner. Jerome E. Tanner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanner, Jerome E. & Caroline Alfieri. (2021). The Fatty Acid Lipid Metabolism Nexus in COVID-19. Viruses. 13(1). 90–90. 60 indexed citations
2.
Sams, Aaron J., Anne Dumaine, Yohann Nédélec, et al.. (2016). Adaptively introgressed Neandertal haplotype at the OAS locus functionally impacts innate immune responses in humans. Genome biology. 17(1). 246–246. 90 indexed citations
3.
Tanner, Jerome E., et al.. (2011). Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication. Journal of Viral Hepatitis. 19(2). e73–80. 9 indexed citations
4.
5.
Tanner, Jerome E., et al.. (2006). Oligonucleotide-Based Therapeutic Options against Hepatitis C Virus Infection. Antiviral Therapy. 11(3). 273–287. 8 indexed citations
6.
Tanner, Jerome E.. (2005). Designing antibodies for oncology. Cancer and Metastasis Reviews. 24(4). 585–598. 11 indexed citations
7.
Tanner, Jerome E., et al.. (2005). Cleavage of intracellular hepatitis C RNA in the virus core protein coding region by deoxyribozymes. Journal of Viral Hepatitis. 13(2). 131–138. 24 indexed citations
8.
Tanner, Jerome E., et al.. (2005). Heat Shock Protein 90 Expression in Epstein-Barr Virus-Infected B Cells Promotes γδ T-Cell Proliferation In Vitro. Journal of Virology. 79(11). 7255–7261. 27 indexed citations
9.
Tanner, Jerome E.. (2004). Nucleosomes activate NF‐κB in endothelial cells for induction of the proangiogenic cytokine IL‐8. International Journal of Cancer. 112(1). 155–160. 16 indexed citations
10.
Tanner, Jerome E., et al.. (2004). Nucleosomes Bind Fibroblast Growth Factor-2 for Increased Angiogenesis In vitro and In vivo. Molecular Cancer Research. 2(5). 281–288. 9 indexed citations
11.
Tanner, Jerome E. & Caroline Alfieri. (2001). The Epstein–Barr virus and post‐transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis. Transplant Infectious Disease. 3(2). 60–69. 91 indexed citations
12.
Tanner, Jerome E., Ming Wei, Caroline Alfieri, et al.. (1997). Antibody and Antibody-Dependent Cellular Cytotoxicity Responses against the BamHI A Rightward Open-Reading Frame-1 Protein of Epstein-Barr Virus (EBV) in EBV-Associated Disorders. The Journal of Infectious Diseases. 175(1). 38–46. 34 indexed citations
13.
Tanner, Jerome E., Francisco Díaz‐Mitoma, Cliona M. Rooney, & Caroline Alfieri. (1997). Anti‐Interleukin‐10 Antibodies in Patients with Chronic Active Epstein‐Barr Virus Infection. The Journal of Infectious Diseases. 176(6). 1454–1461. 20 indexed citations
14.
Tanner, Jerome E., et al.. (1996). Interactions Involving Cyclosporine A., Interleukin-6, and Epstein-Barr Virus Lead to the Promotion of B-Cell Lymphoproliferative Disease. Leukemia & lymphoma. 21(5-6). 379–390. 15 indexed citations
15.
Lassiter, Herbert A., et al.. (1992). Complement Factor 9 Deficiency in Serum of Human Neonates. The Journal of Infectious Diseases. 166(1). 53–57. 39 indexed citations
16.
Tanner, Jerome E., et al.. (1991). United States Department of Agriculture licensing requirements for feline leukemia virus vaccines. Journal of the American Veterinary Medical Association. 199(10). 1402–1406. 4 indexed citations
17.
Tanner, Jerome E. & Giovanna Tosato. (1991). Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice.. Journal of Clinical Investigation. 88(1). 239–247. 81 indexed citations
18.
Lassiter, Herbert A., et al.. (1991). DIMINSHED IGG, BUT NOT COMPLEMENT C3 OR C4 OR FACTOR B, PRECEDES NOSOCOMIAL BECTERIAL SEPSIS IN VERY LOW BIRTH WEIGHT NEONATES. The Pediatric Infectious Disease Journal. 10(9). 663–667. 11 indexed citations
19.
Tanner, Jerome E.. (1990). Biochemical and biological analysis of human interleukin 6 expressed in rodent and primate cells. Cytokine. 2(5). 363–374. 11 indexed citations
20.
Serafini‐Cessi, Franca, Nadia Malagolini, Fabio Dall’Olio, et al.. (1989). Characterization of N- and O-linked oligosaccharides of glycoprotein 350 from Epstein-Barr virus. Virology. 170(1). 1–10. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Menezes Breakdown of academic impact, for papers by S. Finerty Breakdown of academic impact, for papers by Neil Blake Breakdown of academic impact, for papers by Caroline Alfieri Breakdown of academic impact, for papers by Jacqueline M. Burrows Breakdown of academic impact, for papers by Chris Dawson Breakdown of academic impact, for papers by Jianmin Zuo Breakdown of academic impact, for papers by I S Misko Breakdown of academic impact, for papers by Dagmar Pich Breakdown of academic impact, for papers by Misako Yajima
Rankless by CCL
2026